MT-II is a cyclic heptapeptide broadly activating MC1R, MC3R, and MC4R , simultaneously producing melanogenesis alongside central pro-sexual, pro-erectile, and anorectic effects through hypothalamic MC3R/MC4R activation, Cyclisation of the -MSH pharmacophore core is the primary structural determinant of this receptor subtype selectivity shift
Few industries expected GLP-1 drugs to influence alcohol consumption, but evidence is steadily building
Well explain why plaques and tangles arent the wholestory, why singletarget drugs fall short, and how lifestyle andmetabolic factors think insulin and blood sugar matter in prevention
1 2 3 "Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia"
Their largest state is Louisiana